Lipoprotein(a): from ancestral benefit to modern pathogen?

We review current concepts regarding the genetic, structural and metabolic features of lipoprotein(a), a major inherited cardiovascular pathogen. Although lipoprotein(a) is almost completely confined to a subset of primates, the hedgehog produces a lipoprotein(a)-like complex, which appears to have evolved independently from that of humans. The physiological role of lipoprotein(a) in humans is still unclear, and individuals with low or null concentrations of plasma lipoprotein(a) manifest no deficiency syndrome or disease. The integration of recent discoveries about the structure and metabolism of this unique lipoprotein particle has allowed the formulation of some hypotheses concerning the evolutionary advantages of synthesizing lipoprotein(a)-like particles.

[1]  T. Mohandas,et al.  The apolipoprotein(a) gene resides on human chromosome 6q26–27, in close proximity to the homologous gene for plasminogen , 1988, Human Genetics.

[2]  RoryCollins,et al.  Lipoprotein(a) and Coronary Heart Disease , 2000 .

[3]  J. Danesh,et al.  Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies , 2000, Circulation.

[4]  M. Koschinsky,et al.  Lipoprotein(a) and coronary heart disease risk , 1999, Current cardiology reports.

[5]  G. Lippi,et al.  Biochemical risk factors and patient's outcome: the case of lipoprotein(a). , 1999, Clinica chimica acta; international journal of clinical chemistry.

[6]  J. Hixson,et al.  Molecular basis of an apolipoprotein[a] null allele: a splice site mutation is associated with deletion of a single exon. , 1998, Journal of lipid research.

[7]  S. Xu,et al.  Apolipoprotein(a) binds to low-density lipoprotein at two distant sites in lipoprotein(a). , 1998, Biochemistry.

[8]  R. Ramharack,et al.  Dominant Negative Effect of TGF-β1 and TNF-α on Basal and IL-6–Induced Lipoprotein(a) and Apolipoprotein(a) mRNA Expression in Primary Monkey Hepatocyte Cultures , 1998 .

[9]  M. Koschinsky,et al.  Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100. , 1998, Biochemistry.

[10]  G. Utermann,et al.  Intracellular metabolism of human apolipoprotein(a) in stably transfected Hep G2 cells. , 1998, Biochemistry.

[11]  F. España,et al.  Influence of Lipoprotein (a) Levels and Isoforms on Fibrinolytic Activity – Study in Families with High Lipoprotein (a) Levels , 1998, Thrombosis and Haemostasis.

[12]  B. Nordestgaard,et al.  Increased degradation of lipoprotein(a) in atherosclerotic compared with nonlesioned aortic intima-inner media of rabbits: in vivo evidence that lipoprotein(a) may contribute to foam cell formation. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[13]  G. Lippi,et al.  Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[14]  S. Kihara,et al.  Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells. , 1998, Circulation.

[15]  G. Lippi,et al.  Standardization and Clinical Management of Lipoprotein(a) Measurements , 1998, Clinical chemistry and laboratory medicine.

[16]  G. Lippi,et al.  Usefulness of lipids, lipoprotein(a) and fibrinogen measurements in identifying subjects at risk of occlusive complications following vascular and endovascular surgery. , 1998, Scandinavian journal of clinical and laboratory investigation.

[17]  G. Lip,et al.  Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: Implications for increased vascular risk , 1998, Eye.

[18]  K. Kostner,et al.  Metabolism of Lp(a): assembly and excretion , 1997, Clinical genetics.

[19]  W. A. Bradley,et al.  Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[20]  M. Koschinsky,et al.  Analysis of the mechanism of lipoprotein(a) assembly , 1997, Clinical genetics.

[21]  J. Fallon,et al.  The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. , 1997, The Journal of clinical investigation.

[22]  R. Lawn,et al.  Convergent evolution of apolipoprotein(a) in primates and hedgehog. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Harpel,et al.  Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells. , 1997, Circulation.

[24]  N. Yamaguchi,et al.  Molecular cloning of a novel brain-specific serine protease with a kringle-like structure and three scavenger receptor cysteine-rich motifs. , 1997, Biochemical and biophysical research communications.

[25]  A. Zeiher,et al.  Lipoprotein(a) selectively impairs receptor-mediated endothelial vasodilator function of the human coronary circulation. , 1997, Journal of the American College of Cardiology.

[26]  E. Rubin,et al.  Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus. , 1997, The Journal of clinical investigation.

[27]  M. Llinás,et al.  Kringle 5 of Plasminogen is a Novel Inhibitor of Endothelial Cell Growth* , 1997, The Journal of Biological Chemistry.

[28]  T. Simmet,et al.  Lipoprotein(a) is a potent chemoattractant for human peripheral monocytes. , 1997, Blood.

[29]  M. Boffa,et al.  The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface. , 1997, Biochemistry.

[30]  L. Paka,et al.  Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix. , 1997, The Journal of clinical investigation.

[31]  S. Pay,et al.  Elevated Lp(a) is the most frequent familial lipoprotein disorder leading to premature myocardial infarction in a country with low cholesterol levels. , 1997, International journal of cardiology.

[32]  D. Rader,et al.  Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cells. , 1997, Blood.

[33]  B. Nordestgaard,et al.  In vivo transfer of lipoprotein(a) into human atherosclerotic carotid arterial intima. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[34]  A. Noma,et al.  Immunolocalization of Lipoprotein(a) in Wounded Tissues , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[35]  R. Lanford,et al.  Influence of Allelic Variation on Apolipoprotein(a) Folding in the Endoplasmic Reticulum* , 1997, The Journal of Biological Chemistry.

[36]  S. Fortmann,et al.  A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[37]  P. Willmer,et al.  CONVERGENT EVOLUTION IN INVERTEBRATES , 1997, Biological reviews of the Cambridge Philosophical Society.

[38]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[39]  G. Shen,et al.  Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells. , 1997, Atherosclerosis.

[40]  M. O'Reilly.  Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth. , 1997, EXS.

[41]  A. Dirican,et al.  The importance of Lp(a)-fibronectin interaction in atherogenesis. , 1997, Haematologia.

[42]  M. Koschinsky,et al.  The Binding Activity of the Macrophage Lipoprotein(a)/Apolipoprotein(a) Receptor Is Induced by Cholesterol via a Post-translational Mechanism and Recognizes Distinct Kringle Domains on Apolipoprotein(a)* , 1996, The Journal of Biological Chemistry.

[43]  FlorianKronenberg,et al.  Lipoprotein(a) in Stored Plasma Samples and the Ravages of Time , 1996 .

[44]  J. Folkman,et al.  Kringle Domains of Human Angiostatin , 1996, The Journal of Biological Chemistry.

[45]  P. Wilson,et al.  Plasma lipoprotein(a) distribution in the Framingham Offspring Study as determined with a commercially available immunoturbidimetric assay. , 1996, Clinica chimica acta; international journal of clinical chemistry.

[46]  R. Ramharack,et al.  Expression of apolipoprotein[a] and plasminogen mRNAs in cynomolgus monkey liver and extrahepatic tissues. , 1996, Journal of lipid research.

[47]  P. Wilson,et al.  Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. , 1996, JAMA.

[48]  D. O'Neal,et al.  Factors influencing Lp[a]- particle size as determined by gradient gel electrophoresis. , 1996, Journal of lipid research.

[49]  B. Nordestgaard,et al.  Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerotic compared with nonlesioned rabbit aorta. , 1996, The Journal of clinical investigation.

[50]  G. Lippi,et al.  Simple and rapid procedure for the purification of lipoprotein(a). , 1996, Journal of chromatography. B, Biomedical applications.

[51]  M. Koschinsky,et al.  Interaction of a recombinant form of apolipoprotein[a] with human fibroblasts and with the human hepatoma cell line HepG2. , 1996, Journal of lipid research.

[52]  H. Hobbs,et al.  Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature. , 1996, Clinical chemistry.

[53]  M. Yokoyama,et al.  Effects of lipoprotein(a) and low density lipoprotein on growth of mitogen-stimulated human umbilical vein endothelial cells. , 1996, Atherosclerosis.

[54]  H. Hobbs,et al.  Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a). , 1996, The Journal of clinical investigation.

[55]  A. Gotto,et al.  Interaction of apolipoprotein[a] with apolipoproteinB-100 Cys3734 region in lipoprotein[a] is confirmed immunochemically , 1996, Journal of protein chemistry.

[56]  F. Kronenberg,et al.  Lipoprotein(a) in health and disease. , 1996, Critical reviews in clinical laboratory sciences.

[57]  B. G. Brown,et al.  Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). , 1995, JAMA.

[58]  D. Rader,et al.  Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels. A potential role for endothelial cells in lesion formation. , 1995, The American journal of pathology.

[59]  F. Bandello,et al.  Central retinal vein and branch artery occlusion associated with inherited plasminogen deficiency and high lipoprotein(a) levels: a case report. , 1995, Thrombosis research.

[60]  C. Byrne,et al.  The Recurring Evolution of Lipoprotein(a) , 1995, The Journal of Biological Chemistry.

[61]  O. Değer,et al.  Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behçet's disease. , 1995, Annals of the rheumatic diseases.

[62]  L. Yanek,et al.  The Effect of High‐Dose Ascorbate Supplementation on Plasma Lipoprotein(a) Levels in Patients With Premature Coronary Heart Disease , 1995, Pharmacotherapy.

[63]  P. Harpel,et al.  Lipoprotein(a), Plasmin Modulation, and Atherogenesis , 1995, Thrombosis and Haemostasis.

[64]  L. Romics,et al.  High lipoprotein(a) levels with predominance of high molecular weight apo(a) isoforms in patients with pulmonary embolism , 1995 .

[65]  R. Prescott,et al.  Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis , 1995, The Lancet.

[66]  C. Byrne,et al.  Loss of a splice donor site at a 'skipped exon' in a gene homologous to apolipoprotein(a) leads to an mRNA encoding a protein consisting of a single kringle domain. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[67]  T. Blundell,et al.  Molecular evolution and domain structure of plasminogen‐related growth factors (HGF/SF and HGF1/MSP) , 1994, Protein science : a publication of the Protein Society.

[68]  M. L. Snyder,et al.  Subunit composition of lipoprotein(a) protein. , 1994, Biochemistry.

[69]  M. Koschinsky,et al.  Binding of recombinant apolipoprotein(a) to extracellular matrix proteins. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[70]  R. Lawn,et al.  Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice , 1994, Nature.

[71]  K. Berg,et al.  High Lp(a) lipoprotein level in maternal serum may interfere with placental circulation and cause fetal growth retardation , 1994, Clinical genetics.

[72]  R. Pijnenborg,et al.  Immunohistochemical detection of lipoprotein(a) in the wall of placental bed spiral arteries in normal and severe preeclamptic pregnancies. , 1994, Placenta.

[73]  R. Muche,et al.  Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS) , 1994, European journal of clinical investigation.

[74]  T. Gojobori,et al.  Molecular evolution of serine protease and its inhibitor with special reference to domain evolution. , 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[75]  J. Cheng,et al.  The human apolipoprotein(a)/plasminogen gene cluster contains a novel homologue transcribed in liver. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[76]  J. Salonen,et al.  Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. , 1994, Atherosclerosis.

[77]  F. Acquati,et al.  Molecular characterisation of the human apo(a)-plasminogen gene family clustered on the telomeric region of chromosome 6 (6q26-27). , 1994, Human molecular genetics.

[78]  L. Curtiss,et al.  Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[79]  S. Pizzo,et al.  Lipoprotein (a) regulates plasmin generation and inhibition. , 1994, Chemistry and physics of lipids.

[80]  K. Berg.  Lp(a) lipoprotein: an overview. , 1994, Chemistry and physics of lipids.

[81]  P. Ridker,et al.  A prospective study of lipoprotein(a) and the risk of myocardial infarction. , 1993, JAMA.

[82]  Qi Chen,et al.  Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[83]  W. März,et al.  Heterogeneous lipoprotein (a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor‐related protein/α2‐macroglobulin receptor , 1993, FEBS letters.

[84]  H. Hobbs,et al.  Molecular definition of the extreme size polymorphism in apolipoprotein(a). , 1993, Human molecular genetics.

[85]  H. Hoff,et al.  Partial characterization of lipoproteins containing apo[a] in human atherosclerotic lesions. , 1993, Journal of lipid research.

[86]  R. Lawn,et al.  5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[87]  V. Chang,et al.  Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[88]  A. Simon,et al.  Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. The PCVMETRA Group. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[89]  K. Williams,et al.  Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. , 1992, The Journal of biological chemistry.

[90]  A. Ichinose.  Multiple members of the plasminogen-apolipoprotein(a) gene family associated with thrombosis. , 1992, Biochemistry.

[91]  A. Scanu,et al.  Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages. , 1992, The Journal of biological chemistry.

[92]  G. Kostner,et al.  Lipoprotein(a) mediates high affinity low density lipoprotein association to receptor negative fibroblasts. , 1991, The Journal of biological chemistry.

[93]  J. Loscalzo,et al.  Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein. , 1991, Biochemistry.

[94]  J. Huttunen,et al.  Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. , 1991, Atherosclerosis.

[95]  L. Pauling,et al.  Immunological evidence for the accumulation of lipoprotein(a) in the atherosclerotic lesion of the hypoascorbemic guinea pig. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[96]  L. Wilhelmsen,et al.  Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. , 1990, BMJ.

[97]  Scanu Am.  Lipoprotein(a): a genetically determined cardiovascular pathogen in search of a function. , 1990 .

[98]  R. Hammer,et al.  Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. , 1990, The Journal of clinical investigation.

[99]  V. Armstrong,et al.  Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor. , 1990, Journal of lipid research.

[100]  A. Scanu.  Lipoprotein(a): a genetically determined cardiovascular pathogen in search of a function. , 1990, The Journal of laboratory and clinical medicine.

[101]  G. Utermann,et al.  The mysteries of lipoprotein(a). , 1989, Science.

[102]  M. Dietel,et al.  Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. , 1989, Arteriosclerosis.

[103]  C. Mountford,et al.  Elevated apolipoprotein(A) levels in cancer patients , 1989, International journal of cancer.

[104]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[105]  J. Groener,et al.  Lipid transfer protein-catalyzed exchange of cholesteryl ester between high density lipoproteins and apoB-containing lipoproteins. , 1987, Journal of lipid research.

[106]  A. Scanu,et al.  Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a). , 1986, The Journal of biological chemistry.

[107]  J. Berger,et al.  Convergent and parallel evolution: a model illustrating selection, phylogeny and phenetic similarity. , 1977, Bio Systems.